Concepedia

Gerard Vergult

GV

2

Publications

206

Citations

2

H-Index

1993

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Gerard Vergult is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in metabolism, pharmacotherapy, and physiology.

Top concepts

Publications per year

1993–1994

2

Publications

2

Comparison of finasteride (proscar®), a 5α reductase inhibitor, and various commercial plant extracts in in vitro and in vivo 5α reductase inhibition

Linda Rhodes, R. L. Primka, Charles L. Berman et al. · The Prostate · 1993 · 128 citations

Comparison of Finasteride (Proscar®) and Serenoa repens (Permixon®) in the Inhibition of 5-Alpha Reductase in Healthy Male Volunteers

G Strauch, P Perles, Gerard Vergult et al. · European Urology · 1994 · 78 citations

, , +8

Rows per page

1–2 of 2